PTEN mutations in endometrial cancer are generally associated with a favorable prognosis in lower-grade tumors; however, in the context of PDEECs, particularly those that have progressed from lower-grade endometrioid forms, loss of PTEN function is indicative of a more aggressive disease course [57]. This evidence concerns the gene PTEN and endometrial cancer.